# Kaletra in Combination With Antiretroviral Agents

> **NCT01076179** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 502 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01076179
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076179, "Kaletra in Combination With Antiretroviral Agents". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01076179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*